Heptral for fatty liverCreated by:
Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide. The prevalence of NAFLD in the general population of Western countries is 20-30% (http://www.ncbi.nlm.nih.gov/pubmed/20460905). Considering that fatty liver/NAFLD can cause raised liver enzymes, cirrhosis, liver failure and hepatocellular carcinoma, it is a growing lifestyle disease.
However, despite advice on lifestyle changes such as exercise and diet, some patients have problems changing their lifestyle, for various reasons. I see some colleagues prescribing heptral as a hepatoprotective agent. Do any of you do this, or come across any good articles regarding heptral?